Close
Back to ITCI Stock Lookup
Pages: 1 2 »» Last Page

Intra-Cellular Therapies (ITCI) – Globe Newswire

Aug 9, 2022 07:30 AM Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 2, 2022 08:00 AM Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call and Webcast
Jun 13, 2022 08:00 AM Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience
May 10, 2022 07:30 AM Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 3, 2022 08:00 AM Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast
Apr 25, 2022 07:00 AM Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations
Apr 21, 2022 08:00 AM Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
Apr 5, 2022 08:00 AM Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference
Mar 1, 2022 07:30 AM Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Feb 22, 2022 08:00 AM Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast
Feb 10, 2022 08:00 AM Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Jan 7, 2022 04:01 PM Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 4, 2022 10:05 PM Intra-Cellular Therapies Prices Public Offering of Common Stock
Jan 3, 2022 04:01 PM Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Jan 3, 2022 08:00 AM Intra-Cellular Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 20, 2021 06:47 AM Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression in Adults
Dec 6, 2021 04:01 PM Intra-Cellular Therapies Mourns the Passing of Director, Dr. Richard Lerner
Nov 9, 2021 07:30 AM Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 2, 2021 08:00 AM Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call and Webcast
Oct 18, 2021 08:00 AM Intra-Cellular Therapies Announces Amended Start Time to Virtual Event on Wednesday, October 20
Oct 8, 2021 08:00 AM Intra-Cellular Therapies to Host a Virtual Event to Feature Highlights of Several of its Development Programs
Sep 27, 2021 07:30 AM Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of Psychiatry
Sep 22, 2021 08:00 AM Intra-Cellular Therapies to Present at the 2021 Cantor Virtual Global Healthcare Conference
Sep 20, 2021 07:30 AM Intra-Cellular Therapies Announces Publications Highlighting Beneficial Effects of Phosphodiesterase Type I Inhibition with Lenrispodun (ITI-214) on Cardiovascular Function in Patients with Heart Fail
Aug 10, 2021 08:00 AM Intra-Cellular Therapies to Present at the Canaccord Genuity 41st Annual Growth Conference
Aug 9, 2021 07:30 AM Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Aug 2, 2021 08:00 AM Intra-Cellular Therapies to Host Second Quarter 2021 Financial Results Conference Call and Webcast
Jun 7, 2021 08:00 AM CAPLYTA® (lumateperone) Schizophrenia Safety and Tolerability Profile Published in the Journal, International Clinical Psychopharmacology
May 26, 2021 08:00 AM Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences
May 10, 2021 07:30 AM Intra-Cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 5, 2021 08:00 AM Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences
May 4, 2021 08:00 AM Intra-Cellular Therapies to Host First Quarter 2021 Financial Results Conference Call and Webcast
May 3, 2021 07:30 AM Intra-Cellular Therapies Announces FDA Acceptance of CAPLYTA® (lumateperone) sNDAs for the Treatment of Bipolar Depression
Apr 22, 2021 07:30 AM Intra-Cellular Therapies Announces Investor Webcast and Presentations on Lumateperone Programs at the Upcoming American Psychiatric Association (APA) Annual Meeting
Apr 20, 2021 07:00 AM Intra-Cellular Therapies Announces Board of Director Nominations in Advance of 2021 Annual Meeting
Apr 12, 2021 07:30 AM Intra-Cellular Therapies Presents Data on Antitumor Effects of Phosphodiesterase I Inhibition in a Preclinical Colorectal Cancer Model at the 2021 American Association for Cancer Research (AACR) Annua
Feb 25, 2021 07:30 AM Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update
Feb 24, 2021 07:30 AM Intra-Cellular Therapies Announces Expansion of its Pipeline with the Introduction of a New Molecular Entity, ITI-1284
Feb 22, 2021 08:00 AM Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
Feb 19, 2021 08:00 AM Intra-Cellular Therapies to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Feb 17, 2021 08:00 AM Intra-Cellular Therapies to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast
Jan 21, 2021 08:00 AM CAPLYTA® (lumateperone) Open-Label Safety Switching Study in Patients with Schizophrenia Published in the Journal, Schizophrenia Research
Jan 5, 2021 08:00 AM Intra-Cellular Therapies to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 29, 2020 08:00 AM Intra-Cellular Therapies Announces the Initiation of Clinical Trials for ITI-LLAI, a Long-Acting Injectable Formulation of Lumateperone for the Treatment of Schizophrenia and for ITI-333, a Novel Tre
Dec 9, 2020 08:00 AM Intra-Cellular Therapies Highlights Lumateperone Presentations at the 59th Annual Meeting of the American College of Neuropsychopharmacology
Nov 30, 2020 08:00 AM Intra-Cellular Therapies to Present at the Evercore ISI 3rd Annual HealthCONx Conference
Nov 9, 2020 07:30 AM Intra-Cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Nov 4, 2020 08:00 AM Intra-Cellular Therapies to Host Third Quarter 2020 Financial Results Conference Call and Webcast
Oct 1, 2020 04:30 PM Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer
Sep 15, 2020 08:00 AM Intra-Cellular Therapies to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
Pages: 1 2 »» Last Page

Back to ITCI Stock Lookup